share_log

EXCLUSIVE: Pasithea Says 'PAS002 effectively reduces disease severity, delays onset of illness, while also reducing relapse severity'

Benzinga Real-time News ·  Aug 11, 2022 07:34
EXCLUSIVE: Pasithea Says 'PAS002 effectively reduces disease severity, delays onset of illness, while also reducing relapse severity'
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment